Please Read Our Disclaimer

Scientific Review: CCCA Critique – Thomas COVID-19 Vaccines 6 months NEJM

Scientific Review: CCCA Critique – Thomas COVID-19 Vaccines 6 months NEJM

We present several concerns regarding the recent article by Thomas et al. (2) on the efficacy and

safety of the BNT162b2 mRNA coronavirus disease (COVID-19) vaccine, which was published in the

New England Journal of Medicine (NEJM) on November 4, 2021.

Tags: adolescents, adverse effects, adverse events, BNT162b2, CCCA, conflict of interest, COVID, COVID-19, Critique, NEJM, Pfizer, placebo, SAE, SARS-CoV-2, Scientific review, study, Thomas et al, vaccines, virology

Share:

Related Posts

Florida’s Surgeon General challenges the FDA and CDC.

The balance of risks and benefits in the COVID-19 “vaccine hesitancy” literature: An umbrella review

Left unchecked, the arbitrary power of the College of Physicians and Surgeons of BC threatens the health and well-being of all British Columbians as well as the core values of Canadian democracy

Search

Top Categories

WANT TO BECOME A MEMBER?

To learn more about how you can join the Canadian Covid Care Alliance click the link below.

Popular Posts

Real Time Ethics – About Misinformation, Disinformation, and Scientific Discourse

The Endemic Hypothesis: Infectious Clones and Virus Isolation

You’ve been “Nudged”!

The Building Case Against COVID-19 Vaccination of Students in Canada

Letter to Members of the BC Legislative Assembly Requesting the Repeal of the Health Professions and Occupations Act

Stay Connected

Canadian Covid Care Alliance